THORAX

Scope & Guideline

Pioneering insights in pulmonary health.

Introduction

Explore the comprehensive scope of THORAX through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore THORAX in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0040-6376
PublisherBMJ PUBLISHING GROUP
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1946 to 2024
AbbreviationTHORAX / Thorax
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND

Aims and Scopes

The journal 'THORAX' is dedicated to advancing the understanding and treatment of respiratory diseases through high-quality research. It encompasses a broad spectrum of topics related to pulmonary health, focusing on innovative therapies, diagnostic advancements, and the interplay between environmental and social factors impacting lung health.
  1. Respiratory Diseases Research:
    The journal publishes studies that explore various respiratory diseases including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, and lung cancer, emphasizing their pathophysiology, clinical management, and treatment outcomes.
  2. Innovative Diagnostic Techniques:
    A focus on the development and validation of new diagnostic tools and imaging techniques, including the use of artificial intelligence, molecular diagnostics, and advanced imaging methodologies to enhance the accuracy of respiratory disease diagnosis.
  3. Public Health and Respiratory Epidemiology:
    Research on the epidemiology of respiratory diseases, their risk factors, and the impact of public health interventions, with a particular emphasis on vulnerable populations and health disparities.
  4. Clinical Trials and Therapeutics:
    The journal features results from clinical trials assessing new therapies and treatment strategies for respiratory conditions, including biologic therapies, pharmacological interventions, and rehabilitation programs.
  5. Environmental and Occupational Lung Health:
    Studies examining the effects of environmental exposures, occupational hazards, and lifestyle factors on lung health, highlighting the importance of addressing these issues in public health initiatives.
  6. Patient-Centered Research:
    Research focusing on patient experiences, preferences, and outcomes in respiratory care, aiming to improve patient engagement and adherence to treatment protocols.
'THORAX' has seen a dynamic evolution in its research themes, with several emerging topics gaining traction in recent years. These trends reflect the journal's responsiveness to contemporary challenges in respiratory medicine and public health.
  1. Telemedicine and Digital Health:
    The rise of telehealth and digital interventions, especially in the context of the COVID-19 pandemic, has led to an increase in studies exploring their effectiveness in managing respiratory diseases.
  2. Long COVID and Post-Acute Sequelae:
    Research focusing on the long-term effects of COVID-19 on lung health and the broader implications for respiratory function is rapidly increasing, addressing a critical need in post-pandemic care.
  3. Personalized Medicine and Genomics:
    There is a notable trend towards personalized medicine, with studies exploring genetic predispositions and targeted therapies for respiratory diseases, particularly in asthma and interstitial lung disease.
  4. Environmental Impact on Respiratory Health:
    Research examining the relationship between environmental factors, such as air pollution and climate change, and their impact on lung health is gaining prominence, highlighting the need for public health interventions.
  5. Patient-Reported Outcomes and Quality of Life:
    An increasing emphasis on patient-reported outcomes and quality of life measures in clinical research underscores the importance of patient perspectives in the management of respiratory diseases.

Declining or Waning

While 'THORAX' maintains a robust focus on respiratory health, certain areas of research appear to be declining or receiving less emphasis in recent publications. This section highlights these waning themes, reflecting shifts in research priorities and emerging interests.
  1. Traditional Pharmacological Approaches:
    There is a noticeable decrease in studies centered on traditional pharmacological treatments for respiratory diseases, likely due to the growing interest in biologics and personalized medicine.
  2. Single Disease Focus Research:
    Research that exclusively targets single respiratory conditions without considering comorbidities or the broader context of respiratory health appears to be less frequent, indicating a shift towards more integrative approaches.
  3. Basic Science Studies:
    A reduction in basic science research related to lung physiology and pathophysiology may be observed, as the journal focuses more on clinical applications and translational research.
  4. Static Diagnostic Protocols:
    There is a waning interest in static diagnostic protocols that do not incorporate advanced imaging or molecular techniques, reflecting a trend towards more dynamic and multifaceted diagnostic approaches.

Similar Journals

Turkish Thoracic Journal

Transforming the landscape of pulmonary medicine, one study at a time.
Publisher: AVESISSN: Frequency: 6 issues/year

Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.

Lung India

Elevating standards in lung disease management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

Annals of the American Thoracic Society

Pioneering the path in pulmonary and respiratory advancements.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Tuberculosis and Respiratory Diseases

Connecting researchers in the fight against tuberculosis.
Publisher: THE KOREAN ACAD TUBERCULOSIS & RESPIRATORY DISEASESISSN: 1738-3536Frequency: 4 issues/year

Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.

EUROPEAN RESPIRATORY JOURNAL

Elevating Knowledge in Pulmonary Medicine
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

BMJ Open Respiratory Research

Driving breakthroughs in respiratory health for a healthier tomorrow.
Publisher: BMJ PUBLISHING GROUPISSN: Frequency: 1 issue/year

BMJ Open Respiratory Research is a prestigious open access journal published by the BMJ Publishing Group, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2014, the journal has provided a vital platform for the dissemination of innovative research and clinical findings, boasting an impressive Q1 ranking in its category as of 2023. With a Scopus rank of #35 out of 155 in Pulmonary and Respiratory Medicine, BMJ Open Respiratory Research is recognized for its high-quality content, engaging a global audience of researchers, healthcare professionals, and students. The journal embraces an open access model, ensuring that groundbreaking research is readily available to the community and stakeholders, thereby accelerating knowledge exchange and improving patient care. By focusing on diverse aspects of respiratory health, this journal plays a crucial role in shaping the future of respiratory research and practice.

Pulmonary Medicine

Unveiling Breakthroughs in Lung Health
Publisher: HINDAWI LTDISSN: 2090-1836Frequency: 1 issue/year

Pulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.

Thoracic Research and Practice

Elevating Patient Care in Pulmonary Medicine
Publisher: AVESISSN: Frequency: 6 issues/year

Thoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.

Indian Journal of Respiratory Care

Advancing Respiratory Health Through Open Access Research
Publisher: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTDISSN: 2277-9019Frequency: 4 issues/year

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Advancing pulmonary science through rigorous research.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 1040-0605Frequency: 12 issues/year

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.